Literature DB >> 31932268

Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome.

R Cabañas1,2,3,4, E Ramírez2,3,5, E Sendagorta3,6, R Alamar7, R Barranco3,8,9, N Blanca-López10, I Doña11,12, J Fernández13, I Garcia-Nunez14, J García-Samaniego15, R Lopez-Rico16, E Marín-Serrano17, C Mérida18, M Moya19, N R Ortega-Rodríguez20, B Rivas Becerra2,21, P Rojas-Perez-Ezquerra3,22, M J Sánchez-González3,23, C Vega-Cabrera2,21, C Vila-Albelda24, T Bellón2,3,25.   

Abstract

BACKGROUND AND
OBJECTIVE: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a complex multisystemic severe drug hypersensitivity reaction whose diagnosis and management are troublesome. DRESS syndrome requires management by various specialists. The correct identification of the culprit drug is essential to ensure safe future therapeutic options for the patient. There are no previous Spanish guidelines or consensus statements on DRESS syndrome. Objective: To draft a review and guidelines on the clinical diagnosis, allergy work-up, management, treatment, and prevention of DRESS syndrome in light of currently available scientific evidence and the experience of experts from multiple disciplines.
METHODS: These guidelines were drafted by a panel of allergy specialists from the Drug Allergy Committee of the Spanish Society of Allergy and Clinical Immunology (SEAIC), together with other medical specialists involved in the management of DRESS syndrome and researchers from the PIELenRed consortium. A review was conducted of scientific papers on DRESS syndrome, and the expert panel evaluated the quality of the evidence of the literature and provided grades of recommendation. Whenever evidence was lacking, a consensus was reached among the experts.
RESULTS: The first Spanish guidelines on DRESS syndrome are now being published. Important aspects have been addressed, including practical recommendations about clinical diagnosis, identification of the culprit drug through the Spanish pharmacovigilance system algorithm, and the allergy work-up. Recommendations are provided on management, treatment, and prevention. Algorithms for the management of DRESS in the acute and recovery phases have been drawn up. Expert consensus-based stepwise guidelines for the management and treatment of DRESS syndrome are provided.

Entities:  

Keywords:  Corticosteroids; DRESS syndrome; Drug reaction with eosinophilia and systemic symptoms; Drug-induced hypersensitivity syndrome; Lymphocyte transformation test; Patch tests; SCAR; Skin tests

Mesh:

Substances:

Year:  2020        PMID: 31932268     DOI: 10.18176/jiaci.0480

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  6 in total

Review 1.  Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.

Authors:  Hannah Stirton; Neil H Shear; Roni P Dodiuk-Gad
Journal:  Biomedicines       Date:  2022-04-26

Review 2.  Updates and Insights in the Diagnosis and Management of DRESS Syndrome.

Authors:  Elisa Maria Schunkert; Sherrie Jill Divito
Journal:  Curr Dermatol Rep       Date:  2021-11-09

3.  Hypersensitivity to Gadolinium-Based Contrast Media.

Authors:  M Teresa Gracia Bara; Alicia Gallardo-Higueras; Esther M Moreno; Elena Laffond; Francisco J Muñoz Bellido; Cristina Martin; Miriam Sobrino; Eva Macias; Sonia Arriba-Méndez; Rosita Castillo; Ignacio Davila
Journal:  Front Allergy       Date:  2022-03-17

4.  A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2.

Authors:  Jan Walter Schroeder; Chiara Gamba; Andrea Toniato; Franco Rongioletti
Journal:  Clin Dermatol       Date:  2022-05-10       Impact factor: 2.797

5.  Management of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a female Indonesian with pulmonary tuberculosis: A rare case report.

Authors:  Aghnia Permatasari; Gatot Soegiarto
Journal:  Ann Med Surg (Lond)       Date:  2022-08-27

6.  First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test.

Authors:  Araceli Castro Jiménez; Nuria Navarrete Navarrete; Alejandro R Gratacós Gómez; Fernando Florido López; Rosa García Rodríguez; Elisa Gómez Torrijos
Journal:  Contact Dermatitis       Date:  2020-07-28       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.